SBC Medical Group Holdings Inc (SBC)

Currency in USD
5.440
-0.830(-13.24%)
Real-time Data·
SBC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.3406.200
52 wk Range
2.7807.390
Key Statistics
Prev. Close
6.27
Open
6.03
Day's Range
5.34-6.2
52 wk Range
2.78-7.39
Volume
186.47K
Average Volume (3m)
249.34K
1-Year Change
72.1519%
Book Value / Share
2.79
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.000
Upside
+83.82%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.000
(+83.82% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Buy8.00+43.63%-MaintainMar 27, 2026
BTIG
Buy8.00+43.63%-New CoverageMar 06, 2026

SBC Medical Group Holdings Inc Earnings Call Summary for Q3/2026

  • SBC Medical Q3 FY2026 EPS of $0.15 beat estimates by $0.03; revenue rose 35% YoY to $58.58M, topping forecasts by $9.69M; shares jumped 9.74%.
  • Operating income surged 66% YoY while adjusted EBITDA margin expanded 9 points to 47%, demonstrating strong operating leverage in MSO model.
  • Same-clinic revenue grew 7% over nine months; network expanded to 293 locations with customer visits up 9% and average spend per visit rising 4%.
  • Management plans continued clinic expansion, longevity services launch targeting 2028 revenue, and AI tool investments including proprietary LLM development.
  • U.S. expansion expected within 6-12 months; capital allocation prioritizes M&A and clinic growth over buybacks; governance improvements underway.
Last Updated: 2026-11-13, 09:18 a/m
Read Full Transcript

Earnings

Latest Release
Nov 13, 2026
EPS / Forecast
0.15 / 0.12
Revenue / Forecast
58.58M / 48.89M
EPS Revisions
Last 90 days

SBC Income Statement

Compare SBC to Peers and Sector

Metrics to compare
SBC
Peers
Sector
Relationship
P/E Ratio
12.4x−0.2x−0.2x
PEG Ratio
0.590.080.00
Price/Book
2.2x3.3x2.6x
Price / LTM Sales
3.4x1.4x2.7x
Upside (Analyst Target)
77.3%32.9%69.6%
Fair Value Upside
Unlock4.5%11.7%Unlock

SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.88M1.82%11.59M
Other Institutional Investors
2.93M2.85%18.11M
Public Companies & Retail Investors
98.04M95.33%605.89M
Total
102.85M100.00%635.6M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Lumbard & Kellner, LLC1.68%1,727,20810,674
BlackRock, Inc.0.90%924,0025,710

People Also Watch

47.99
CIX
-1.76%
8.060
TKNO
+2.28%
7.690
IMC
+0.65%
37.17
CCB
-0.58%
4.510
BUUU
-7.01%

FAQ

What Is the SBC Medical Holdings (SBC) Stock Price Today?

The SBC Medical Holdings stock price today is 5.440 USD.

What Stock Exchange Does SBC Medical Holdings Trade On?

SBC Medical Holdings is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for SBC Medical Holdings?

The stock symbol for SBC Medical Holdings is "SBC."

What Is the SBC Medical Holdings Market Cap?

As of today, SBC Medical Holdings market cap is 644.850M USD.

What Is SBC Medical Holdings's Earnings Per Share (TTM)?

The SBC Medical Holdings EPS (TTM) is 0.51.

When Is the Next SBC Medical Holdings Earnings Date?

SBC Medical Holdings will release its next earnings report on Mar 26, 2027.

From a Technical Analysis Perspective, Is SBC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has SBC Medical Holdings Stock Split?

SBC Medical Holdings has split 0 times.

How Many Employees Does SBC Medical Holdings Have?

SBC Medical Holdings has 863 employees.

What is the current trading status of SBC Medical Holdings (SBC)?

As of Nov 19, 2026, SBC Medical Holdings (SBC) is trading at a price of 5.440 USD, with a previous close of 6.270 USD. The stock has fluctuated within a day range of 5.340 USD to 6.200 USD, while its 52-week range spans from 2.780 USD to 7.390 USD.

What Is SBC Medical Holdings (SBC) Price Target According to Analysts?

The average 12-month price target for SBC Medical Holdings is 10.000 USD, with a high estimate of 12 USD and a low estimate of 7 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +83.82% Upside potential.

What Is the SBC Premarket Price?

SBC's last pre-market stock price is 6.050 USD. The pre-market share volume is 12,530.000, and the stock has decreased by -0.220, or -3.510%.

What Is the SBC After Hours Price?

SBC's last after hours stock price is 6.320 USD, the stock has decreased by 0.050, or 0.800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.